The venture capital market rebounded in 2017, with an uptick in deal flow, an increase in financing sizes, soaring proceeds and a record high median premoney valuation. The $73.2 billion invested into the US venture capital...more
An increasingly common financing strategy for companies expecting to conduct an initial public offering (IPO), particularly in the life sciences space, is to conduct a ‘‘crossover’’ financing shortly prior to the IPO....more
11/21/2017
/ Capital Raising ,
Corporate Financing ,
Disclosure Requirements ,
Due Diligence ,
General Solicitation ,
Initial Public Offering (IPO) ,
Investment Funds ,
Investors ,
Section 5 ,
Securities Act of 1933 ,
Shareholders